ELEVANCE HEALTH, INC. (ELV) FY2024 Annual Statement of Cash Flows

Income StatementCash FlowBalance Sheet

Statement of Cash Flows

2024-01-01 to 2024-12-31

Swipe to see the full flow
ELEVANCE HEALTH, INC. cash flow reconciliation, Jan 1, 2024 through Dec 31, 2024One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Orange marks positive customer-advance and deferred-revenue changes that add to operating cash in the reconciliation. These are net changes, not gross customer receipts. Negative changes are neutral reconciliation adjustments; they do not by themselves identify cash payments. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net income → Net cash from operating activities: $5,808,000,000.00Net income → Operating adjustments reconciliation: $163,000,000.00Depreciation and amortization → Operating adjustments reconciliation: $1,393,000,000.00Other assets → Operating adjustments reconciliation: $824,000,000.00Net losses on financial instruments → Operating adjustments reconciliation: $445,000,000.00Income taxes → Operating adjustments reconciliation: $404,000,000.00Share-based compensation → Operating adjustments reconciliation: $191,000,000.00Impairment of property, equipment and right-of-use assets → Operating adjustments reconciliation: $103,000,000.00Other, net → Operating adjustments reconciliation: $39,000,000.00Operating adjustments reconciliation → Policy liabilities: $1,840,000,000.00Operating adjustments reconciliation → Receivables, net: $683,000,000.00Operating adjustments reconciliation → Deferred income taxes: $374,000,000.00Operating adjustments reconciliation → Accounts payable and other liabilities: $272,000,000.00Operating adjustments reconciliation → Gain on sale of business: $201,000,000.00Operating adjustments reconciliation → Unearned income: $113,000,000.00Operating adjustments reconciliation → Other invested assets: $78,000,000.00Operating adjustments reconciliation → Equity in net earnings (losses) of other invested assets: $1,000,000.00Proceeds from long-term borrowings → financing reconciliation: $7,710,000,000.00Proceeds from short-term borrowings → financing reconciliation: $275,000,000.00Proceeds from issuance of common stock under employee stock plans → financing reconciliation: $221,000,000.00Other, net → financing reconciliation: $2,000,000.00financing reconciliation → Net cash from financing activities: $1,193,000,000.00financing reconciliation → Repurchase and retirement of common stock: $2,900,000,000.00financing reconciliation → Repayments of long-term borrowings: $1,650,000,000.00financing reconciliation → Cash dividends: $1,508,000,000.00financing reconciliation → Changes in bank overdrafts: $638,000,000.00financing reconciliation → Repayments of short-term borrowings: $135,000,000.00financing reconciliation → Taxes paid through withholding of common stock under employee stock plans: $109,000,000.00financing reconciliation → Changes in securities lending payable: $75,000,000.00Net cash used in investing activities → investing reconciliation: $5,167,000,000.00Proceeds from sale of investments → investing reconciliation: $16,547,000,000.00Maturities, calls and redemptions from investments → investing reconciliation: $2,025,000,000.00Proceeds from sales of subsidiaries, net of cash sold → investing reconciliation: $363,000,000.00Changes in securities lending collateral → investing reconciliation: $73,000,000.00investing reconciliation → Purchases of investments: $17,986,000,000.00investing reconciliation → Purchases of subsidiaries, net of cash acquired: $4,809,000,000.00investing reconciliation → Purchases of property and equipment: $1,256,000,000.00investing reconciliation → Other, net: $124,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $6,526,000,000.00Net cash from operating activities → Cash sources and uses: $5,808,000,000.00Net cash from financing activities → Cash sources and uses: $1,193,000,000.00Cash sources and uses → Exchange-rate effect: $6,000,000.00Cash sources and uses → Difference in the filed cash totals (calculated): $66,000,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $8,288,000,000.00Cash sources and uses → Net cash used in investing activities: $5,167,000,000.00Impairment of property, equipment and right-of-use assets: $103,000,000.00Asset impairments+$103.00 MOther assets: $824,000,000.00Other operating assets+$824.00 MReceivables, net: -$683,000,000.00Receivables, net−$683.00 MDeferred income taxes: -$374,000,000.00Deferred income taxes−$374.00 MPolicy liabilities: -$1,840,000,000.00Insurance liabilities−$1.84 BIncome taxes: $404,000,000.00Income taxes, net+$404.00 MOther, net: $39,000,000.00Other working capital, net+$39.00 MAccounts payable and other liabilities: -$272,000,000.00Payables & other liabilities−$272.00 MOther invested assets: -$78,000,000.00Trading securities, net−$78.00 MEquity in net earnings (losses) of other invested assets: -$1,000,000.00Equity-method results−$1.00 MDepreciation and amortization: $1,393,000,000.00D&A and accretion+$1.39 BNet losses on financial instruments: $445,000,000.00Net losses on financial instruments+$445.00 MNet income: $5,971,000,000.00Net income+$5.97 BShare-based compensation: $191,000,000.00Stock-based compensation+$191.00 MUnearned income: -$113,000,000.00Unearned revenue−$113.00 MGain on sale of business: -$201,000,000.00Business sale gain & loss−$201.00 MNet cash from operating activities: $5,808,000,000.00Operating cash+$5.81 BOperating adjustments reconciliation: $3,562,000,000.00Proceeds from short-term borrowings: $275,000,000.00Short-term debt issued+$275.00 MProceeds from long-term borrowings: $7,710,000,000.00Long-term debt issued+$7.71 BOther, net: $2,000,000.00Other financing, net+$2.00 MChanges in bank overdrafts: -$638,000,000.00Outstanding checks, net−$638.00 MRepayments of short-term borrowings: -$135,000,000.00Short-term debt repaid−$135.00 MTaxes paid through withholding of common stock under employee stock plans: -$109,000,000.00Stock-award tax withholding−$109.00 MChanges in securities lending payable: -$75,000,000.00Securities lending, net−$75.00 MCash dividends: -$1,508,000,000.00Dividends paid−$1.51 BRepayments of long-term borrowings: -$1,650,000,000.00Long-term debt repaid−$1.65 BProceeds from issuance of common stock under employee stock plans: $221,000,000.00Stock plan proceeds+$221.00 MRepurchase and retirement of common stock: -$2,900,000,000.00Common stock repurchases−$2.90 BNet cash from financing activities: $1,193,000,000.00Financing cash+$1.19 Bfinancing reconciliation: $8,208,000,000.00Maturities, calls and redemptions from investments: $2,025,000,000.00AFS securities maturities+$2.03 BChanges in securities lending collateral: $73,000,000.00Securities loan collateral, net+$73.00 MPurchases of investments: -$17,986,000,000.00Investment purchases−$17.99 BPurchases of subsidiaries, net of cash acquired: -$4,809,000,000.00Acquisitions, net of cash−$4.81 BProceeds from sale of investments: $16,547,000,000.00Proceeds from sale of investments+$16.55 BOther, net: -$124,000,000.00Other investing, net−$124.00 MPurchases of property and equipment: -$1,256,000,000.00PP&E purchases−$1.26 BProceeds from sales of subsidiaries, net of cash sold: $363,000,000.00Business sales, net of cash+$363.00 MNet cash used in investing activities: -$5,167,000,000.00. Cash required to fund net payments.Investing cash−$5.17 Binvesting reconciliation: $24,175,000,000.00Cash sources and uses: $13,527,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $6,526,000,000.00Beginning cash$6.53 BEnding cash: Cash, cash equivalents, and restricted cash: $8,288,000,000.00Ending cash$8.29 BExchange-rate effect: -$6,000,000.00FX effect−$6.00 MDifference in the filed cash totals (calculated): -$66,000,000.00Filer's cash difference(calculated)−$66.00 MCASH RECONCILIATIONOperatingflowsFinancingflowsInvestingflowsFree cash flow$4.55 BOperating cash − cash spent on PP&ECash flow / Net income0.97×Operating cash flow ÷ net incomeNet cash change+$1.76 BEnding cash − beginning cash
Chart details

ELEVANCE HEALTH, INC. cash flow reconciliation, Jan 1, 2024 through Dec 31, 2024

Cash flows for Jan 1, 2024 through Dec 31, 2024. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 31, 2023. Ending cash: Dec 31, 2024. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Dec 31, 2023
6,526,000,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
5,808,000,000 US dollars. Net cash provided.
Impairment of property, equipment and right-of-use assets
103,000,000 US dollars
Other assets
824,000,000 US dollars
Receivables, net
negative 683,000,000 US dollars
Deferred income taxes
negative 374,000,000 US dollars
Policy liabilities
negative 1,840,000,000 US dollars
Income taxes
404,000,000 US dollars
Other, net
39,000,000 US dollars
Accounts payable and other liabilities
negative 272,000,000 US dollars
Other invested assets
negative 78,000,000 US dollars
Equity in net earnings (losses) of other invested assets
negative 1,000,000 US dollars
Depreciation and amortization
1,393,000,000 US dollars
Net losses on financial instruments
445,000,000 US dollars
Net income
5,971,000,000 US dollars
Share-based compensation
191,000,000 US dollars
Unearned income
negative 113,000,000 US dollars
Gain on sale of business
negative 201,000,000 US dollars
Investing activities
negative 5,167,000,000 US dollars. Net cash used.
Maturities, calls and redemptions from investments
2,025,000,000 US dollars
Changes in securities lending collateral
73,000,000 US dollars
Purchases of investments
negative 17,986,000,000 US dollars
Purchases of subsidiaries, net of cash acquired
negative 4,809,000,000 US dollars
Proceeds from sale of investments
16,547,000,000 US dollars
Other, net
negative 124,000,000 US dollars
Purchases of property and equipment
negative 1,256,000,000 US dollars
Proceeds from sales of subsidiaries, net of cash sold
363,000,000 US dollars
Financing activities
1,193,000,000 US dollars. Net cash provided.
Proceeds from short-term borrowings
275,000,000 US dollars
Proceeds from long-term borrowings
7,710,000,000 US dollars
Other, net
2,000,000 US dollars
Changes in bank overdrafts
negative 638,000,000 US dollars
Repayments of short-term borrowings
negative 135,000,000 US dollars
Taxes paid through withholding of common stock under employee stock plans
negative 109,000,000 US dollars
Changes in securities lending payable
negative 75,000,000 US dollars
Cash dividends
negative 1,508,000,000 US dollars
Repayments of long-term borrowings
negative 1,650,000,000 US dollars
Proceeds from issuance of common stock under employee stock plans
221,000,000 US dollars
Repurchase and retirement of common stock
negative 2,900,000,000 US dollars
Operating adjustment reconciliation
3,562,000,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
8,208,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
24,175,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
negative 6,000,000 US dollars
Difference in the filed cash totals (calculated)
negative 66,000,000 US dollars. Out of cash; drawn as the small gray flow above ending cash.
Ending cash on Dec 31, 2024
8,288,000,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
13,527,000,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
1,762,000,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
0.97×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
5,808,000,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
1,256,000,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
4,552,000,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income exceeds operating cash. The diagram allocates $5.81B of net income directly to operating cash and $163.00M to the adjustment junction, where it combines with other additions to reconcile deductions. This is an accounting presentation, not a tracing of cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • The filer's reported cash figures differ by $66.00 M: its ending cash less its beginning cash does not equal its reported net change in cash. The chart shows the difference as its own calculated flow; no reported amount has been adjusted.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 5,808,000,000 US dollars minus 1,256,000,000 US dollars equals 4,552,000,000 US dollars.
  • The filer's reported cash figures differ by $66.00 M: its ending cash less its beginning cash does not equal its reported net change in cash. The chart shows the difference as its own calculated flow; no reported amount has been adjusted.
ELEVANCE HEALTH, INC. (ELV) FY2024 Annual Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!